Cost-effectiveness of fluvastatin following successful first percutaneous coronary intervention.

about

A systematic literature review of methods of incorporating mortality in cost-effectiveness analyses of lipid-lowering therapies.

P2860

Q38754290-CB3EF65B-DB8C-4809-8493-B6B47F957879

P2860

Cost-effectiveness of fluvastatin following successful first percutaneous coronary intervention.

Item

http://www.wikidata.org/entity/Q40441608

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Cost-effectiveness of fluvasta ...... taneous coronary intervention.

@en

type

Item

label

Cost-effectiveness of fluvasta ...... taneous coronary intervention.

@en

prefLabel

Cost-effectiveness of fluvasta ...... taneous coronary intervention.

@en

P1476

Cost-effectiveness of fluvasta ...... taneous coronary intervention.

@en

P2093

Gerry Oster

http://www.w3.org/2001/XMLSchema#string

John S Edelsberg

http://www.w3.org/2001/XMLSchema#string

Patrick W J C Serruys

http://www.w3.org/2001/XMLSchema#string

Thomas E Delea

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

A paclitaxel-eluting stent for the prevention of coronary restenosis

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

Quality of life in the first 100 days after suspected acute myocardial infarction--a suitable trial endpoint?

Willingness to pay for a quality-adjusted life year: in search of a standard.

Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis.

Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.

Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.

Unsuccessful emergency medical resuscitation--are continued efforts in the emergency department justified?

P304

610-616

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1E367

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Terry A. Jacobson

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15741421

http://www.w3.org/2001/XMLSchema#string

Cost-effectiveness of fluvastatin following successful first percutaneous coronary intervention.

about

P2860

P2860

Cost-effectiveness of fluvastatin following successful first percutaneous coronary intervention.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698